The panelists identify some of the drivers of the new healthcare delivery models, discuss some of the recent innovations in healthcare delivery, and also express concern that new delivery models may lead to a loss of coordination of care.
“One driver of change on the delivery side is value-based purchasing,” declares Ateev Mehrotra, MD, MPH, associate professor of health care policy and medicine at Harvard Medical School, Boston, and a hospitalist at Beth Israel Deaconess Medical Center, Medfield, Massachusetts. Many small primary care providers lack resources and have limited staff, says Dr Mehrotra, but they need to handle “the capital costs and hardware that are necessary for implementing the electronic health record,” which is essential to quality measurement and reporting initiatives.
New innovations in healthcare delivery include retail clinics, urgent care centers, electronic visits, coaching navigators, and even nurse practitioners who come directly to a patient’s home. All of this is “really exciting for patients, because they have a lot more choices available to them,” comments Dr Mehrotra. If a new delivery model is readily available and convenient, he believes the result will be greater utilization and increased healthcare spending.
the panelists admit that even if a new healthcare delivery model creates faster, more efficient care that is also of good quality, not every plan will reimburse for these services. Arthur Vercillo, MD, FACS, a surgeon and regional president of Excellus Blue Cross Blue Shield, is in favor of convenient local care. His concern, though, is that some patients may visit different clinics, urgent care centers, and drugstores, jeopardizing coordination of care, and “I really think we want to head toward delivery systems with coordinated care,” he says.
Reviving the Classics: The Role of Older Medications in Modern Dermatology
March 9th 2025Older, generic medications, including ones for cyclosporine, nicotinamide, and dapsone, can effectively treat patients with various dermatological conditions while helping to reduce insurance and cost barriers.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Use of AI Lets Health System Find Lung Cancer at Early Stages
March 8th 2025Artificial intelligence (AI) helps a Sarasota, Florida, health system catch lung nodules that appear on CT scans for patients treated for scores of conditions, allowing them to be referred for a possible lung cancer diagnosis.
Read More
Shaping Dermatology's Future by Increasing Access, Data, and Advocacy
March 7th 2025Thy N. Huynh, MD, FAAD, Bruce A. Brod, MHCI, MD, FAAD, and Melissa Piliang, MD, FAAD, discussed expanding access to pediatric dermatology, dermatology data aggregation, and advocacy for Medicare physician payment reform, respectively.
Read More